609 related articles for article (PubMed ID: 29065913)
1. Urine S100 proteins as potential biomarkers of lupus nephritis activity.
Turnier JL; Fall N; Thornton S; Witte D; Bennett MR; Appenzeller S; Klein-Gitelman MS; Grom AA; Brunner HI
Arthritis Res Ther; 2017 Oct; 19(1):242. PubMed ID: 29065913
[TBL] [Abstract][Full Text] [Related]
2. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
3. Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment.
Davies JC; Midgley A; Carlsson E; Donohue S; Bruce IN; Beresford MW; Hedrich CM
RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723832
[TBL] [Abstract][Full Text] [Related]
4. Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE).
Donohue SJ; Midgley A; Davies JC; Wright RD; Bruce I; Beresford MW; Hedrich CM; ;
Clin Immunol; 2020 May; 214():108375. PubMed ID: 32135275
[TBL] [Abstract][Full Text] [Related]
5. Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity.
Burcsár S; Toldi G; Kovács L; Szalay B; Vásárhelyi B; Balog A
Biomarkers; 2021 Jul; 26(5):443-449. PubMed ID: 33825610
[TBL] [Abstract][Full Text] [Related]
6. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
Badr AMM; Farag Y; Abdelshafy M; Riad NM
Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660
[TBL] [Abstract][Full Text] [Related]
7. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
[TBL] [Abstract][Full Text] [Related]
8. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
Front Immunol; 2022; 13():885307. PubMed ID: 35720325
[TBL] [Abstract][Full Text] [Related]
9. Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis.
Xue J; Yang J; Yang L; Zhou S; Ji C; Wang X; Yu N; Liu X; Chi S
J Immunol Res; 2017; 2017():6861575. PubMed ID: 28373995
[TBL] [Abstract][Full Text] [Related]
10. IFN-γ, CXCL16, uPAR: potential biomarkers for systemic lupus erythematosus.
Wen S; He F; Zhu X; Yuan S; Liu H; Sun L
Clin Exp Rheumatol; 2018; 36(1):36-43. PubMed ID: 28628472
[TBL] [Abstract][Full Text] [Related]
11. Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study.
Šumová B; Cerezo LA; Szczuková L; Nekvindová L; Uher M; Hulejová H; Moravcová R; Grigorian M; Pavelka K; Vencovský J; Šenolt L; Závada J
Rheumatol Int; 2019 Mar; 39(3):469-478. PubMed ID: 30392117
[TBL] [Abstract][Full Text] [Related]
12. Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus.
Picard C; Lega JC; Ranchin B; Cochat P; Cabrera N; Fabien N; Belot A
Pediatr Nephrol; 2017 Sep; 32(9):1537-1545. PubMed ID: 28343355
[TBL] [Abstract][Full Text] [Related]
13. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
[TBL] [Abstract][Full Text] [Related]
14. Urinary prostaglandin D synthase as biomarker in lupus nephritis: a longitudinal study.
Gupta R; Yadav A; Misra R; Aggarwal A
Clin Exp Rheumatol; 2015; 33(5):694-8. PubMed ID: 26211517
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis.
Ding H; Kharboutli M; Saxena R; Wu T
Clin Exp Immunol; 2016 Apr; 184(1):11-8. PubMed ID: 26616478
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
He D; Liu M; Liu B
Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of progranulin in patients with lupus nephritis and its correlation with disease activity.
Wu J; Wei L; Wang W; Zhang X; Chen L; Lin C
Rheumatol Int; 2016 Jun; 36(6):759-67. PubMed ID: 26968845
[TBL] [Abstract][Full Text] [Related]
18. Urine β2-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus.
Choe JY; Park SH; Kim SK
Lupus; 2014 Dec; 23(14):1486-93. PubMed ID: 25124677
[TBL] [Abstract][Full Text] [Related]
19. Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.
Tydén H; Lood C; Gullstrand B; Jönsen A; Ivars F; Leanderson T; Bengtsson AA
Lupus; 2017 Feb; 26(2):139-149. PubMed ID: 27407135
[TBL] [Abstract][Full Text] [Related]
20. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]